Skip to main content

Posts

Sensex Plunges Over 810 Points Nifty Drops Below 9,000 to 8967

Domestic stock markets gave in to losses led by financial stocks in late afternoon deals on Tuesday, as global markets continued in touch the brunt of the fallout of the coronavirus outbreak. The S&P BSE Sensex index plummeted the maximum amount as 995.13 points from the previous on the brink of hit 30,394.94 on the downside, and therefore the broader NSE Nifty 50 benchmark declined to as low as 8,915.60, down 281.8 points from the previous close. Those losses came in stark contrast compared to intraday highs of 32,047.98 and 9,403.80 touched by the Sensex and Nifty respectively within the half of the session. At 3:23 pm, the Sensex traded 855.52 points (2.73 per cent) lower at 30,534.55, and therefore the Nifty was down 243.45 (2.65 per cent) at 8,953.95. Thirty six stocks within the Nifty basket of fifty shares moved lower at the time. the most important losers in percentage terms were Zee Entertainment, ICICI Bank, IndusInd Bank, Bharti Infratel, UPL and Tata Motors, down be...

Nifty 50 stocks

Nifty 50 stocks List:- Adani Ports & Speci Asian Paints Ltd. Axis Bank Ltd. Bajaj Auto Ltd. Bajaj Finance L Bajaj Finserv Ltd. Bharat Petroleum Bharti Airtel Bharti Infratel Ltd. Britannia Ind. Cipla Coal India Dr. Reddy's Labs Eicher Motors GAIL (India) Ltd. Grasim Inds. HCL Technologies HDFC HDFC Bank Hero MotoCorp Hindalco Indus. Hindustan Unilever L ICICI Bank ITC Ltd. Indian Oil Corp IndusInd Bank Infosys JSW Steel Kotak Mahindra Bank L&T Mahi. & Mahi Maruti Suzuki India NTPC Nestle India ONGC Power Grid Corpo Reliance Inds. SBI Sun Pharma. Tata Consultancy Tata Motors Ltd. Tata Steel Tech Mahindra Ltd. Titan Company UPL UltraTech Cement Vedanta Wipro Ltd YES Bank Ltd. Zee Entertainment En

SUN PHARMA IN DETAILS

SUN PHARMA'S HISTORY Sun Pharmaceuticals was founded by Mr. Dilip Shanghvi in ​​1983 in Vapi, Gujarat with five products for the treatment of psychiatric diseases. Cardiology products were introduced in 1987 by Gastroenterology Products in 1989. Today, it is the largest chronic prescription company in India and a market leader in psychiatry, neurology, cardiology, orthopedics, ophthalmology, gastroenterology and nephrology. The 2014 acquisition of Ranbaxy has made the company the largest pharma company in India, the largest Indian pharma company in the US, and the 5th largest specialty generic company globally. More than 72% of Sun Pharma's sales are from markets outside India, mainly in the states. The US is the largest market, accounting for about 50% of turnover; All, formulations or finished dosage forms, account for 93% of the turnover. Manufacturing is at 26 locations including plants in the US, Canada, Brazil, Mexico and Israel. In the US, the company markets a la...

INFOSYS

INFOSYS Q2 Sep 2019 Revenue 19666 Crore V/S Sep 2018 revenue 18297 crore and Sep 2019  Net profit: 3829 crore v/s Sep 2018 Net Profit: 3879 crore down by around 2%. Dividend Oct 2019 declared Rupees 8/- per share